Sarcoidosis in the setting of combination ipilimumab and nivolumab immunotherapy: a case report & review of the literature.

Reuss, Joshua E; Kunk, Paul R; Stowman, Anne M; Gru, Alejandro A; Slingluff, Craig L; Gaughan, Elizabeth M

Reuss, Joshua E; Kunk, Paul R; Stowman, Anne M; Gru, Alejandro A; Slingluff, Craig L; Gaughan, Elizabeth M.

Afiliación

Reuss JE; Department of Medicine, Division of Hematology-Oncology, University of Virginia Health System, PO Box 800716, Charlottesville, 22908 VA USA.
Kunk PR; Department of Medicine, Division of Hematology-Oncology, University of Virginia Health System, PO Box 800716, Charlottesville, 22908 VA USA.
Stowman AM; Department of Pathology, Division of Anatomic Pathology, University of Virginia Health System, PO Box 800716, Charlottesville, 22908 VA USA.
Gru AA; Department of Pathology, Division of Anatomic Pathology, University of Virginia Health System, PO Box 800716, Charlottesville, 22908 VA USA.
Slingluff CL; Department of Surgery, Division of Surgical Oncology, University of Virginia Health System, PO Box 800716, Charlottesville, 22908 VA USA.
Gaughan EM; Department of Medicine, Division of Hematology-Oncology, University of Virginia Health System, PO Box 800716, Charlottesville, 22908 VA USA.

J Immunother Cancer ; 4: 94, 2016.

Article en En | MEDLINE | ID: mdl-28031822

Palabras clave

Checkpoint inhibitor; Combination immunotherapy; Immune-related adverse event; Ipilimumab; Metastatic melanoma; Nivolumab; Sarcoidosis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: J Immunother Cancer Año: 2016 Tipo del documento: Article Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google